EV71 vaccine
Commercial- Indications
- Hand, foot, and mouth disease
Company intelligence / Profile preview
Kalventis Sinergi Farma
East Jakarta, Jakarta, Indonesiakalventis.co.id ↗
- Ownership
- Private
- Employees
- ~36
- Development stage
- Commercial
01
Overview
Kalventis is a commercial pharmaceutical company with multiple products on the market, including vaccines, diabetes medications, and cardiovascular treatments.
- Therapeutic areas
- EndocrinologyCardiovascularInfectious Diseases
- Modalities
- Small moleculesvaccines
- Industry
- Pharma
02
Drug pipeline
1 asset03
Partnerships
Ministry of HealthPERKENI (Indonesian Endocrinology Association)PERALMUNIIDAI JABAR
Beyond the preview
Go deeper on Kalventis Sinergi Farma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kalventis Sinergi Farma.